Improving medication adherence in chronic obstructive pulmonary disease: A systematic review

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Bryant, Jamie ^a   McDonald, Vanessa M ^a,b   Boyes, Allison ^a   Sanson Fisher, Rob ^a   Paul, Christine ^a   Melville, Jessica ^a  

^a HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Chronic obstructive pulmonary disease; Medication adherence; Medication compliance; Systematic review

Indexed keywords

CAREGIVER; CHRONIC OBSTRUCTIVE LUNG DISEASE; COCHRANE LIBRARY; COST EFFECTIVENESS ANALYSIS; COUNSELING; DATA BASE; DRUG DELIVERY DEVICE; HEALTH CARE COST; HEALTH CARE PERSONNEL; HUMAN; INHALER; MEDICAL RESEARCH; MEDICATION COMPLIANCE; MEDLINE; MONITORING; PHARMACIST; PRACTICE GUIDELINE; REVIEW; SAMPLE SIZE; SELF CARE; SURVIVAL; SYSTEMATIC REVIEW; NEBULIZER; TREATMENT OUTCOME;

ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT;

ANTI-INFLAMMATORY AGENTS; BRONCHODILATOR AGENTS; HUMANS; MEDICATION ADHERENCE; NEBULIZERS AND VAPORIZERS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SELF CARE; TREATMENT OUTCOME;

EID: 84885504675     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-109     Document Type: Review

References (58)

1. Agustí AGN, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003, 21:347-360. 10.1183/09031936.03.00405703, 12608452.
2. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009, 33:1165-1185. 10.1183/09031936.00128008, 19407051.
3. Halbert R, Natoli J, Gano A, Badamgarav E, Buist A, Mannino D. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006, 28:523-532. 10.1183/09031936.06.00124605, 16611654.
4. Feenstra T, van Genugten M, Hoogenveen R, Wouters E, Rutten-van Molken M. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med 2001, 164:590-596. 10.1164/ajrccm.164.4.2003167, 11520721.
5. Murray C, Lopez A. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997, 349:1498-1504. 10.1016/S0140-6736(96)07492-2, 9167458.
6. Kanervisto M, Saarelainen S, Vasankari T, Jousilahti P, Heistaro S, Heliövaara H, Luukkaala T, Paavilainen E. COPD, chronic bronchitis and capacity for day-to-day activities: negative impact of illness on thehealth-related quality of life. Chron Respir Dis 2010, 7:207-215. 10.1177/1479972310368691, 21084545.
7. Jones PW, Brusselle G, Dal Negro RW, Ferrerd M, Kardose P, Levyf ML, Perezg T, Soler-Cataluñah JJ, van der Moleni T, Adamekj L, Banikk N. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med 2011, 105:57-66. 10.1016/j.rmed.2010.09.004, 20932736.
8. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R, Shekelle P, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the american college of physicians, american college of chest physicians, american thoracic society, and european respiratory society. Ann Intern Med 2011, 155:179-191. 10.7326/0003-4819-155-3-201108020-00008, 21810710.
9. Toy EL, Beaulieu NU, McHale JM, Welland TR, Plauschinat CA, Swensen A, Duh MS. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med 2011, 105:435-441. 10.1016/j.rmed.2010.09.006, 20880687.
10. Vestbo J, Anderson JA, Calverley PMA, Celli B, Ferguson GT, Jenkins C, Knobil K, Willits LR, Yates JC, Jones PW. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009, 64:939-943. 10.1136/thx.2009.113662, 19703830.
11. Antoniu SA. Adherence to inhaled therapy in COPD: effects on survival and exacerbations. Expert Rev Pharmacoecon Outcomes Res 2010, 10:115-117. 10.1586/erp.10.10, 20384558.
12. Asche CV, Leader S, Plauschinat C, Raparla S, Yan M, Ye X, Young D. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids. Int J Chron Obstruct Pulmon Dis 2012, 7:201-209. 3324995, 22500120.
13. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005, 353:487-497. 10.1056/NEJMra050100, 16079372.
14. Bosley C, Corden Z, Rees P, Cochrane G. Psychological factors associated with the use of home nebulized therapy for COPD. Eur Respir J 1996, 9:2346-2350. 10.1183/09031936.96.09112346, 8947083.
15. Taylor DR, Kinney CD, McDevitt DC. Patient compliance with oral theophylline therapy. Br J Clin Pharmacol 1984, 17:15-20. 10.1111/j.1365-2125.1984.tb04992.x, 1463295, 6691884.
16. Bosley CM, Parry DT, Cochrane GM. Patient compliance with inhaled medication. Does combining beta agonists with corticostroids improve compliance?. Eur Respir J 1994, 7:504-509. 10.1183/09031936.94.07030504, 8013609.
17. Ramsey SD. Suboptimal medical therapy in COPD: exploring the causes and concequences. Chest 2000, 117:33S-37S. 10.1378/chest.117.2_suppl.33S, 10673472.
18. James P, Anderson J, Prior J, White J, Henry J, Cochrane G. Patterns of drug taking in patients with chronic airflow obstruction. Postgrad Med J 1985, 61:7-10.
19. Corden Z, Bosley C, Rees O, Cochrane G. Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life. Chest 1997, 112:1278-1282. 10.1378/chest.112.5.1278, 9367468.
20. Turner J, Wright E, Mendella L, Anthonisen N, the IPPB Study Group Predictors of patient adherence to long-term home nebulizer therapy for COPD. Chest 1995, 108:394-400. 10.1378/chest.108.2.394, 7634873, the IPPB Study Group.
21. Dolce JJ, Crisp C, Manzella B, Richards JM, Hardin JM, Bailey WC. Medication adherence patterns in chronic obstructive pulmonary disease. Chest 1991, 99:837-841. 10.1378/chest.99.4.837, 2009784.
22. Goeman DP, Douglass JA. Optimal management of asthma in elderly patients: strategies to improve adherence to recommended interventions. Drugs Aging 2007, 24:381-394. 10.2165/00002512-200724050-00003, 17503895.
23. Banning M. Older people and adherence with medication: a review of the literature. Int J Nurs Stud 2008, 45:1550-1561. 10.1016/j.ijnurstu.2008.02.009, 18395727.
24. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006, 130:65S-72S. 10.1378/chest.130.1_suppl.65S, 16840369.
25. George J, Kong DCM, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest 2005, 128:3198-3204. 10.1378/chest.128.5.3198, 16304262.
26. McDonald VM, Higgins I, Gibson PG. Managing older patients with coexistent asthma and COPD: diagnostic and therapeutic challenges. Drugs Aging 2013, 30:1-17. 10.1007/s40266-012-0042-z, 23229768.
27. Gibson PG, McDonald VM, Marks GB. Asthma in the older adult. Lancet 2010, 374:803-813.
28. Krigsman K, Moen J, Nilsson JL, Ring L. Refill adherence by the elderly for asthma/chronic obstructive pulmonary disease drugs dispensed over a 10-year period. J Clin Pharm Ther 2007, 32:603-611. 10.1111/j.1365-2710.2007.00866.x, 18021338.
29. Franssen FME, Spruit MA, Wouters EFM. Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2011, 6:493-501. 3206765, 22069360.
30. Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, Sikkema-Ortiz J, Gardner DD, Wilkins RL. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis 2008, 3:371-384. 2629978, 18990964.
31. George J, Kong DC, Stewart K. Adherence to disease management programs in patients with COPD. Int J Chron Obstruct Pulmon Dis 2007, 2:253-262. 2695203, 18229563.
32. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA 2002, 288:2469-2475. 10.1001/jama.288.19.2469, 12435261.
33. Commodore-Mensah Y, Dennison Himmelfarb CR. Patient education strategies for hospitalized cardiovascular patients: a systematic review. J Cardiovasc Nurs 2012, 27:154-174. 10.1097/JCN.0b013e318239f60f, 22210147.
34. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004, 27:1218-1224. 10.2337/diacare.27.5.1218, 15111553.
35. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002, 288:2868-2879. 10.1001/jama.288.22.2868, 12472329.
36. Kripalani S, Yao X, Haynes B. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 2007, 167:540-549. 10.1001/archinte.167.6.540, 17389285.
37. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 2003, 60:657-665.
38. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care 1998, 36:1138-1161. 10.1097/00005650-199808000-00004, 9708588.
39. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008, (2). 10.1002/14651858.CD000011.pub3.
40. Rand CS. Patient adherence with COPD therapy. Eur Respir Rev 2005, 14:97-101.
41. Royal Pharmaceutical Society of Great Britain From compliance to concordance; achieving shared goals in medicine taking 1997, London: Royal Pharmaceutical Society of Great Britain, Royal Pharmaceutical Society of Great Britain.
42. Cochrane Effective Practice and Organisation of Care Review Group Data Collection Checklist 2002, Ontario, Canada: Cochrane Effective Practice and Organisation of Care Group, Accessed 01/02/2013, Cochrane Effective Practice and Organisation of Care Review Group.
43. De Tullio PL, Kirking DM, Arslanian C, Olson DE. Compliance measure development and assessment of theophylline therapy in ambulatory patients. J Clin Pharm Ther 1987, 12:19-26.
44. Nides MA, Tashkin DP, Simmons MS, Wise RA, Li VC, Rand CS. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest 1993, 104:501-507. 10.1378/chest.104.2.501, 8339641.
45. Simmons MS, Nides MA, Rand CS, Wise RA, Tashkin DP. Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest 1996, 109:963-968. 10.1378/chest.109.4.963, 8635378.
46. Solomon D, Portner T, Bass G, Gourley D, Gourley G, Holt J, Wicke W, Braden R, Eberle T, Self T, Lawrence B. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc 1998, 38:574-585.
47. Gallefoss F, Bakke PS. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. Am J Respir Crit Care Med 1999, 160:2000-2005. 10.1164/ajrccm.160.6.9901028, 10588620.
48. Garcia-Aymerich J, Hernandez C, Alonso A, Casas A, Rodriguez-Roisin R, Anto JM, Roca J. Effects of an integrated care intervention on risk factors of COPD readmission. Respir Med 2007, 101:1462-1469. 10.1016/j.rmed.2007.01.012, 17339106.
49. Jarab AS, Alqudah SG, Khdour M, Shamssain M, Mukattash TL. Impact of pharmaceutical care on health outcomes in patients with COPD. Int J Clin Pharm 2012, 34:53-62. 10.1007/s11096-011-9585-z, 22101426.
50. Khdour MR, Kidney JC, Smyth BM, McElnay JC. Clinical pharmacy-led disease and medicine management programme for patients with COPD. Br J Clin Pharmacol 2009, 68:588-598. 10.1111/j.1365-2125.2009.03493.x, 2780284, 19843062.
51. Anthonisen NR. Lung health study. Am Rev Respir Dis 1989, 140:871-872. 10.1164/ajrccm/140.4.871, 2529803.
52. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circ 2009, 119:3028-3035.
53. Lareau SC, Yawn VP. Improving adherence with inhaler therapy in COPD. Int J Chron Obstruct Pulmon Dis 2010, 5:401-406. 3008325, 21191434.
54. McDonald VM, Higgins I, Simpson JL, Gibson PG. The importance of clinical management problems in older people with COPD and asthma: do patients and physicians agree?. Prim Care Respir J 2011, 20:389-395. 10.4104/pcrj.2011.00025, 21448550.
55. Wilson S, Strub P, Buist A, Knowles S, Lavori P, Lapidus J, Vollmer W, Better Outcomes of Asthma Treatment (BOAT) Study Group Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med 2010, 181:566-577. 10.1164/rccm.200906-0907OC, 2841026, 20019345, Better Outcomes of Asthma Treatment (BOAT) Study Group.
56. Cabana MD, Slish KK, Evans D, Mellins RB, Brown RW, Lin X, Kaciroti N, Clark NM. Impact of physician asthma care education on patient outcomes. Pediatr 2006, 117:2149-2157.
57. Hunt CK. Concepts in caregiver research. J Nurs Scholarsh 2003, 35:27-32. 10.1111/j.1547-5069.2003.00027.x, 12701523.
58. Trivedi RB, NBryson CL, Udris E, Au DH. The influence of informal caregivers on adherence in COPD patients. Ann Behav Med 2012, 44:66-72. 10.1007/s12160-012-9355-8, 22422104.